3D生物印刷公司比科的在由前员工和匿名消息人士对他提出的管理不善的指控后，董事会将其重量抛在了公司少首席执行官Erik Gatenholm之后。
在2022年4月27日发表的一篇文章中，古斯汀·丹尼尔森（Gusten Danielsson）告诉报纸达根斯工业公司（Dagens Industri）Gatenholm “was no longer the right CEO对于公司而言，”辞去其首席财务官后不久。从那时起，该公司的股票暴跌了41％，匿名消息人士现在说，BICO的首席执行官被指控对员工的“情感滥用爆发”，但董事会坚定地继续支持他。
“Due to speculations, we on the Board of Directors want to make it clear that we are fully united behind the CEO, the management team and the strategy with focus on profitability,” said Carsten Browall, Chairman of BICO’s Board of Directors. “The company has great potential and is now entering an important stage for the future.”
当由3D印刷行业与指控做出回应时，BICO发表了一份回收的声明，重申董事会仍然落后于Gatenholm先生，并将其更广泛的承诺重申对“以盈利能力为中心的战略”。
The allegations against Gatenholm
BICO的公关噩梦开始了，据报道，盖滕霍尔姆和丹尼尔斯森之间的争执，后者辞去了他的立场。However, while BICO labelled the decision a “necessary and natural change in strategy,” Danielsson went to the press, claiming that while he hadn’t sold his shares, he blamed Gatenholm for the firm’s poor stock performance, and didn’t see him as the right man to be CEO.
随着公司的股价开始进一步下跌，3D打印行业随后获得了消息来源的提示，后者声称对Gatenholm的其他指控有内幕信息。实际上，消息人士说，BICO现任首席执行官不适合经营该公司的信念实际上在整个公司中占有广泛的控制，但是由于他拥有控制权的股份：“几乎没有人可以阻止他。”
They also allege that BICO has engaged in “mass layoffs” since January, including “cutting the marketing, design engineering and communications teams,” and accuse Gatenholm of personally forcing staff to positively review their experience of working there.
消息人士解释说：“有人抱怨他的管理风格，导致员工当场辞职。”“如果您看Glassdoor，您可以看到一些负面评论，以及一些假埃里克（Erik）向员工施加压力的假评论。”雷竞技在线登录
While it’s unclear if this source is a disgruntled BICO employee, investor or otherwise, their claims around the firm’s restructuring appear justified. The company is reported to have made at least 23 comms-related layoffs, and with the likes of Qi Huan Sng and Mikael Engblom also being appointed the business’ new APAC Marketing Manager and temporary CFO, it has undergone an internal shake-up.
为了回应这些指控，BICO的首席人民埃里卡·贝尔（Erica Bell）表示，“该组织没有大规模裁员”。相反，贝尔坚持认为，该公司在第四季度“进行了重组”，该公司在BICO的某些职位变得过时了。贝尔补充说，这反过来又看到了受影响的员工的替代或重新分配，但有些人选择拒绝这些报价。
A costly public dispute for BICO
在丹尼尔斯辞职之前，比科的股价为16.54美元，但事实证明，截至周二的纠纷的公共性质已经昂贵，截至今年跌至9.77美元。BICO的挫折还改变了该公司扩张的故事，该公司试图促进“生物综合”，购买其他生物技术公司，以利用协同效应，将其变成更负面的公司。
在过去的一年左右的时间里，BICO有acquired the MatTek Corporation，，，，bought Nanoscribe for €50 million和以8000万欧元的价格购买了Scienion在其投资组合的其他添加中。3D印刷行业的匿名消息人士称，正是这些“伟大的公司/员工”是其当前处境的“真正的受害者”，因为他们的“命运与一家运营的公司相关”。
However, while BICO’s share price decline reflects the reputational damage Danielsson’s exit has caused it to suffer, it’s not the first time the firm has found its name being dragged through the mud. In August 2021, it became clear thatOrganovo正在寻求BICO Firm Cellink的特许权使用费声称它已经出售了与“ 3D印刷和药物开发”有关的技术，该技术依靠其IP。
At the time, CELLINK told 3D Printing Industry that these claims were “invalid,” but despite this, it chose to settle what had turned into a string of lawsuits and counter-suits, by许可Organovo的技术in March 2022. Given that until the agreement, Organovo had begun to struggle in finding new sources of revenue, the deal was viewed as a success by its investors, which sent its shares soaring 53%.
Bioprinting’s lucrative potential
尽管BICO股价最近的崩溃代表了其寻求生物综合的挫折，但毫无疑问，它仍然是3D Biopinting领域的领导者，具有对投资者有吸引力的潜在高核未来的未来。
今年早些时候，再生医学初创企业愈合形状设法筹集了680万美元3D生物打印患者特定的乳房植入物。该公司的组织由患者自己的活细胞制成，旨在治疗乳腺癌后接受乳房切除术手术的女性。
Similarly, albeit at a larger scale, industry stalwarts like3D系统还在开发自己的3D生物打印产品中耕种大量资源。宣布了打印到灌注突破去年年初，company opted to buy Volumetric Biotechnologiesin a deal that could be worth up to $400 million, and has since enabled it to expand its bioprinting research.
To stay up to date with the latest 3D printing news, don’t forget to subscribe to the3D打印行业通讯or follow us onTwitter或喜欢我们的页面Facebook。
要深入研究添加剂制造，您现在可以订阅我们的雷电竞充值Youtubechannel, featuring discussion, debriefs, and shots of 3D printing in-action.
您是否正在寻找增材制造业的工作？雷电竞充值访问3D打印作业for a selection of roles in the industry.
Featured image shows BICO CEO Erik Gatenholm. Photo via the Swedish-American Chambers of Commerce.
